ESR1 and breast cancer: When comparing subjects’ pre- and post-intervention serum in vitro, using 3 estrogen receptor-positive breast cancer cell lines, there was a significant decrease in cell growth and increase in apoptosis concurrent with improvements in biomarkers following the diet and lifestyle intervention.